XML 36 R23.htm IDEA: XBRL DOCUMENT
v3.10.0.1

NOTE 16 - SEGMENT AND RELATED INFORMATION | 12 Months Ended
--- | ---
Jun. 30, 2018
Segment Reporting [Abstract] |
NOTE 16 - SEGMENT AND RELATED INFORMATION | FONAR CORPORATION AND SUBSIDIARIES NOTES TO CONSOLIDATED FINANCIAL STATEMENTS JUNE 30, 2018, 2017 and 2016 NOTE 16 - SEGMENT AND RELATED INFORMATION The Company provides segment data in accordance with the provisions of ASC topic 280, “Disclosures about Segments of an Enterprise and Related Information”. The Company operates in two industry segments - manufacturing and the servicing of medical equipment and management of diagnostic imaging centers. The accounting policies of the segments are the same as those described in the summary of significant accounting policies. All intersegment sales are market-based. The Company evaluates performance based on income or loss from operations. Summarized financial information concerning the Company’s reportable segments is shown in the following table:
|  | Manufacturing and Servicing of Medical Equipment |  | Management of Diagnostic Imaging Centers |  | Totals
Fiscal 2018: |  |  |  |  |  |
Net revenues from external customers |  | $ | 9,837,269 |  |  | $ | 71,678,725 |  |  | $ | 81,515,994 |
Intersegment net revenues * |  | $ | 901,250 |  |  | $ | — |  |  | $ | 901,250 |
(Loss) Income from operations |  | $ | (2,982,778 | ) |  | $ | 22,666,989 |  |  | $ | 19,684,211 |
Depreciation and amortization |  | $ | 353,307 |  |  | $ | 3,546,544 |  |  | $ | 3,899,851 |
Compensatory element of stock issuances |  | $ | — |  |  | $ | — |  |  | $ | — |
Total identifiable assets |  | $ | 32,364,298 |  |  | $ | 85,946,647 |  |  | $ | 118,310,945 |
Capital expenditures |  | $ | 346,608 |  |  | $ | 2,540,169 |  |  | $ | 2,886,777 |
Fiscal 2017: |  |  |  |  |  |  |  |  |  |  |  |
Net revenues from external customers |  | $ | 11,219,188 |  |  | $ | 66,817,398 |  |  | $ | 78,036,586 |
Intersegment net revenues * |  | $ | 1,200,000 |  |  | $ | — |  |  | $ | 1,200,000 |
(Loss) Income from operations |  | $ | (2,292,312 | ) |  | $ | 21,388,392 |  |  | $ | 19,096,080 |
Depreciation and amortization |  | $ | 324,550 |  |  | $ | 3,209,014 |  |  | $ | 3,533,564 |
Compensatory element of stock issuances |  | $ | 2,397,276 |  |  | $ | — |  |  | $ | 2,397,276 |
Total identifiable assets |  | $ | 28,103,809 |  |  | $ | 69,658,676 |  |  | $ | 98,762,566 |
Capital expenditures |  | $ | 212,983 |  |  | $ | 2,793,331 |  |  | $ | 3,006,314 |
Fiscal 2016: |  |  |  |  |  |  |  |  |  |  |  |
Net revenues from external customers |  | $ | 10,783,618 |  |  | $ | 62,584,592 |  |  | $ | 73,368,210 |
Intersegment net revenues * |  | $ | 2,140,000 |  |  | $ | — |  |  | $ | 2,140,000 |
Income from operations |  | $ | (1,979,497 | ) |  | $ | 16,335,113 |  |  | $ | 14,355,616 |
Depreciation and amortization |  | $ | 320,843 |  |  | $ | 2,976,446 |  |  | $ | 3,297,289 |
Compensatory element of stock issuances |  | $ | 2,006 |  |  | $ | — |  |  | $ | 2,006 |
Total identifiable assets |  | $ | 28,241,501 |  |  | $ | 56,646,105 |  |  | $ | 84,887,606 |
Capital expenditures |  | $ | 437,695 |  |  | $ | 387,593 |  |  | $ | 825,288 |
* Amounts eliminated in consolidation Export Product Sales The Company’s areas of operations are principally in the United States. The Company had export sales of medical equipment amounting to 41.5%, 55.9% and 19.6% of product sales revenues to third parties for the years ended June 30, 2018, 2017 and 2016, respectively. The foreign product sales, as a percentage of product sales to unrelated parties, were made to customers in the following countries:
|  | For the Years Ended June 30,
|  | 2018 |  | 2017 |  | 2016
United Arab Emirates |  |  | 7.1 | % |  |  | 45.4 | % |  |  | -% |
Switzerland |  |  | — |  |  |  | — |  |  |  | — |
Canada |  |  | — |  |  |  | — |  |  |  | 0.3 |
England |  |  | 29.9 |  |  |  | 4.8 |  |  |  | 18.5 |
Germany |  |  | 4.5 |  |  |  | — |  |  |  | .6 |
Puerto Rico |  |  | — |  |  |  | 5.7 |  |  |  | .2 |
|  |  | 41.5 | % |  |  | 55.9 | % |  |  | 19.6 | %
Foreign Service and Repair Fees The Company’s areas of service and repair are principally in the United States. The Company had foreign revenues of service and repair of medical equipment amounting to 5.0%, 4.6% and 5.8% of consolidated net service and repair fees for the years ended June 30, 2018, 2017 and 2016, respectively. Foreign service and repair fees, as a percentage of total service and repair fees, were provided principally to the following countries:
|  | For the Years Ended June 30,
|  | 2018 |  | 2017 |  | 2016
Spain |  |  | -% |  |  |  | -% |  |  |  | 0.3 | %
Puerto Rico |  |  | 1.5 |  |  |  | 1.2 |  |  |  | 1.5 |
Switzerland |  |  | 0.2 |  |  |  | 0.2 |  |  |  | 0.3 |
Germany |  |  | 1.3 |  |  |  | 1.4 |  |  |  | 1.5 |
England |  |  | 0.6 |  |  |  | 0.5 |  |  |  | 0.5 |
United Arab Emirates |  |  | 0.3 |  |  |  | — |  |  |  | — |
Canada |  |  | — |  |  |  | 0.1 |  |  |  | 0.3 |
Greece |  |  | 0.2 |  |  |  | 0.2 |  |  |  | 0.2 |
Australia |  |  | 0.9 |  |  |  | 1.0 |  |  |  | 1.2 |
|  |  | 5.0 | % |  |  | 4.6 | % |  |  | 5.8 | %
The Company does not have any material assets outside of the United States.

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -URI http://asc.fasb.org/topic&trid=2134510 + Details
Name: | us-gaap_SegmentReportingDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration